# FDA Inspection 974682 - Lerman, Mark, MD - May 26, 2016

Source: https://www.keypedia.com/records/fda_inspections/lerman-mark-md/243cca51-1d7d-4e73-a7bd-055a7e84771e
Source feed: FDA_Inspections

> FDA Inspection 974682 for Lerman, Mark, MD on May 26, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 974682
- Company Name: Lerman, Mark, MD
- Inspection Date: 2016-05-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 775834 - 2012-04-04](https://www.keypedia.com/records/fda_inspections/lerman-mark-md/95f4b72a-43c1-4dc8-aa57-021d974c027c)

Company: https://www.keypedia.com/companies/lerman-mark-md/a1377f00-4879-409a-8acc-ce4bc72e8fc7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c